ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
AB Corporate Bond ETF

AB Corporate Bond ETF (EYEG)

37.08
0.03
(0.07%)
Closed September 20 4:00PM
37.08
0.00
( 0.00% )
Pre Market: 4:09AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
37.08
Bid
14.91
Ask
58.95
Volume
-
0.00 Day's Range 0.00
1.95 52 Week Range 37.24
Market Cap
Previous Close
37.08
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
805
Shares Outstanding
7,689,000
Dividend Yield
-
PE Ratio
-2.16
Earnings Per Share (EPS)
-1.7
Revenue
-
Net Profit
-13.05M

About AB Corporate Bond ETF

The Fund is an actively-managed exchange-traded fund (ETF). The Fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers. Corporate issuers m... The Fund is an actively-managed exchange-traded fund (ETF). The Fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers. Corporate issuers may include corporate or other business entities in which a sovereign or governmental agency or entity may have, indirectly or directly, an interest, including a majority or greater ownership interest. The Funds investment objective is to maximize total return through current income and longterm capital appreciation. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
AB Corporate Bond ETF is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker EYEG. The last closing price for AB Corporate Bond ETF was $37.08. Over the last year, AB Corporate Bond ETF shares have traded in a share price range of $ 1.95 to $ 37.24.

AB Corporate Bond ETF currently has 7,689,000 shares outstanding. The market capitalization of AB Corporate Bond ETF is $285.11 million. AB Corporate Bond ETF has a price to earnings ratio (PE ratio) of -2.16.

EYEG Latest News

EyeGate Pharmaceuticals to Present at BIO CEO & Investor Conference in New York City

WALTHAM, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today announced that the Company will attend and present at the 21st...

EyeGate Pharmaceuticals Announces Meeting Date with FDA

WALTHAM, Mass., Jan. 16, 2019 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today confirmed that it is scheduled to meet with the U.S. Food and...

EyeGate Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today announced financial results for the three-month period ended...

EyeGate Pharma Announces Positive Results in Second PRK Study

Data confirms results from earlier study WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) today announced top-line data from its study evaluating...

EyeGate Pharmaceuticals Signs Technology Transfer and License Agreement with SentrX Animal Care

WALTHAM, Mass., Oct. 02, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Pharmaceuticals Granted Additional 180 Days to Comply With Nasdaq Listing Rules

WALTHAM, Mass., Sept. 25, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Pharmaceuticals Completes Enrollment in Both PRK and PE Pilot Studies

WALTHAM, Mass., Sept. 24, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Announces Randomization of First Patients in Study for Punctate Epitheliopathies

WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Announces Top-Line Results for Phase 3 Trial of EGP-437 in Anterior Uveitis

WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.105-0.28237192416337.18537.2437.0588437.07197611SP
40.391.0629599345936.6937.2436.465125336.84548341SP
122.06165.8871907340135.018437.2435.018480536.48326568SP
261.51434.2577539595735.565737.2434.5274835.73235364SP
5235.131801.538461541.9537.241.9540835.74152865SP
15635.291971.508379891.7937.241.73728932.0901276SP
26033.751013.513513513.3337.241.442250193.64654334SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NVVENuvve Holding Corporation
$ 7.11
(81.38%)
4.18M
SOXMTradr 2X Long SOXX Monthly ETF
$ 36.96
(58.98%)
57
NUKKNukkleus Inc
$ 0.3138
(47.67%)
18.49M
TGLTreasure Global Inc
$ 0.98
(44.05%)
2.72M
BDTXBlack Diamond Therapeutics Inc
$ 6.38
(34.03%)
1.8M
ZJYLJin Medical International Ltd
$ 3.14
(-23.04%)
42.24k
AACGATA Creativity Global
$ 0.40
(-21.61%)
1
SMXTSolarMax Technology Inc
$ 0.7029
(-19.75%)
214
ADTXAditxt Inc
$ 0.3114
(-18.61%)
79.25k
CJETChijet Motor Company Inc
$ 2.28
(-18.57%)
793
NUKKNukkleus Inc
$ 0.3138
(47.67%)
18.49M
LGCBLinkage Global Inc
$ 0.5466
(30.67%)
12.44M
MAXNMaxeon Solar Technologies Ltd
$ 0.0844
(-7.76%)
4.45M
NVVENuvve Holding Corporation
$ 7.11
(81.38%)
4.18M
GSIWGarden Stage Ltd
$ 1.64
(22.39%)
4.09M

Discussion

View Full Feed
stocksrising stocksrising 2 minutes ago
Item 8.01 Other Events.
On August 16, 2024, Revance Therapeutics, Inc. (the "Company" or "Revance") received a notice to remedy alleged material breaches, including breaches of the maximum levels of buffer stock and required efforts to promote and sell Teoxane products, under the Company's ex
RVNC
WithEyesOpen WithEyesOpen 2 minutes ago
Ridiculous Hopium
NBRI
1vman 1vman 3 minutes ago
***** 🅰️🅰️🅰️ DBMM has had 1 name change , 3 ticker symbol changes and 2 R/S

SOURCE
https://www.otcmarkets.com/stock/DBMM/security

ENOUGH SAID
DBMM
alertmeipp alertmeipp 3 minutes ago
Seems Teoxane is using its leverage.

They got the notice on Aug 16.

Revance Therapeutics received a notice from Teoxane SA alleging material breaches of their exclusive distribution agreement, including buffer stock levels and promotion efforts. Revance denies these c
RVNC
SkeBallLarry SkeBallLarry 3 minutes ago
* LIVE* ~ President Donald J. Trump >

45th President of the United States of America,
will hold a rally in >
Indiana, Pennsylvania

on Monday, September 23, 2024, at 7:00 p.m. EDT.

Watch LIVE on RSBN starting at 12 p.m. ET.
T
SkeBallLarry SkeBallLarry 3 minutes ago
* LIVE* ~ President Donald J. Trump >

45th President of the United States of America,
will hold a rally in >
Indiana, Pennsylvania

on Monday, September 23, 2024, at 7:00 p.m. EDT.

Watch LIVE on RSBN starting at 12 p.m. ET.
T
surfkast surfkast 4 minutes ago
AND BY BASHING I MEAN JUST TELLING THE TRUTH ABOUT WHAT SCAM THE STOCK AND THE AZZHATS THAT ARE PUMPING IT ARE -- and those idiots might just take it higher. Who knows? Maybe .25 cents or even higher??? What is the ceiling on STUPIDITY?

Hard to tell!

It still happens. L
IGPK
SkeBallLarry SkeBallLarry 4 minutes ago
* LIVE* ~ President Donald J. Trump >

45th President of the United States of America,
will hold a rally in >
Indiana, Pennsylvania

on Monday, September 23, 2024, at 7:00 p.m. EDT.

Watch LIVE on RSBN starting at 12 p.m. ET.
T
SkeBallLarry SkeBallLarry 5 minutes ago
* LIVE* ~ President Donald J. Trump >

45th President of the United States of America,
will hold a rally in >
Indiana, Pennsylvania

on Monday, September 23, 2024, at 7:00 p.m. EDT.

Watch LIVE on RSBN starting at 12 p.m. ET.
T
Awl416 Awl416 5 minutes ago
Black Diamond Therapeutics Announces Initial Phase 2 Data Demonstrating Robust Anti-tumor Activity of BDTX-1535 in Patients with Recurrent EGFRm NSCLC who Present with a Broad Spectrum of Classical, Non-classical, and C797S Resistance Mutations
BDTX
Humbert Humbert 5 minutes ago
Great news, hinting that the higher estimates for the financials may be closer to the mark. I think we could possibly see ~$50mm reported, or more.

JMN's products look poised to make a huge impact.

People can read the rest here: BNCM: DELEX Acquisition of JMN BROTHERS
BNCM
bigstocksnbonds bigstocksnbonds 5 minutes ago
Have a good day!!!!
Mpphotopro Mpphotopro 6 minutes ago
Watching close for entry.  Seeing a lot of buzz on twitter
XXII
ChannelTrader ChannelTrader 7 minutes ago
Says it all BDEZ
reena969 reena969 9 minutes ago
Mark I mean no harm , however .45 to .75 was the move and .50 to .75 (bollinger band support https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175123753 ) was the second play, however I could be wrong anything else is just a waste of time because I'm not seeing a 65% plus gain in LGCB
LGCB
ChannelTrader ChannelTrader 9 minutes ago
Watch: Megyn Kelly Destroys Liberal Host on Trump Trials in a Brilliant Legal Display

https://truthpress.com/news/watch-megyn-kelly-destroys-liberal-host-on-trump-trials-in-a-brilliant-legal-display/?utm_source=truthpress.beehiiv.com&utm_medium=newsletter&utm_campaign=secret-service-a
oystersnbeer oystersnbeer 9 minutes ago
Trump's behavior is certain to get more erratic and desperate, his dangerous rhetoric even more hateful and violent.

https://x.com/TheDemCoalition/status/1838153959938175201
arachnodude arachnodude 10 minutes ago
This facility was built to address the production space requirements for 2025 and to create a foundation for future expansion. With this proven production blueprint established, the Company anticipates building out additional production capacity in 2025 to bring additional silk production capacity o
KBLB
Monksdream Monksdream 10 minutes ago
What will grow legs afterv9:30
https://ih.advfn.com/markets/nasdaq/premarket
SkeBallLarry SkeBallLarry 10 minutes ago
* LIVE* ~ President Donald J. Trump >

45th President of the United States of America,
will hold a rally in >
Indiana, Pennsylvania

on Monday, September 23, 2024, at 7:00 p.m. EDT.

Watch LIVE on RSBN starting at 12 p.m. ET.
T
MrSmithLWLG MrSmithLWLG 11 minutes ago
Good interview. Lebby thinks he is close, (“the future”), is that 1 year or 5 years ? The market and stock price would suggest is further out. Time will tell.
LWLG
work-n-hard work-n-hard 12 minutes ago
LGCB: is this simply a bounce play, or are there other factors?
LGCB
PegnVA PegnVA 13 minutes ago
TFG adopts Bernie Sanders' plan for price control - cap interest rate on credit cards.

Your Recent History

Delayed Upgrade Clock